
Adamas Pharmaceuticals, Inc. ADMS
Adamas Pharmaceuticals, Inc. DIO Ratio 2011-2026 | ADMS
Annual DIO Ratio Adamas Pharmaceuticals, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 1.31 K | 779 | 2.95 K | 36.6 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.6 K | 779 | 10.4 K |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acasti Pharma
ACST
|
136 | - | 4.01 % | $ 150 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.83 | 1.13 % | $ 4.53 M | ||
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Acorda Therapeutics
ACOR
|
345 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
26.1 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
Arena Pharmaceuticals
ARNA
|
160 | - | -6.81 % | $ 3.04 B | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Bristol-Myers Squibb Company
BMY
|
68.7 | $ 59.99 | 0.1 % | $ 122 B | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.65 | -0.37 % | $ 4.53 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
Aytu BioScience
AYTU
|
209 | $ 2.2 | -3.08 % | $ 13.8 M |